Proactiveinvestors USA & Canada Verona Pharma https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Verona Pharma RSS feed en Tue, 20 Aug 2019 15:30:02 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - Verona Pharma plc: PDMR Dealing ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7692005-en/ Fri, 09 Aug 2019 04:35:27 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7692005-en/ <![CDATA[RNS press release - Verona Pharma plc: Operational Update and Financial Results for the Three and Six Months Ended June 30, 2019 ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7689402-en/ Tue, 06 Aug 2019 02:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7689402-en/ <![CDATA[RNS press release - Verona Pharma Reports Positive Phase 2 Results with Dry Powder Inhaler Formulation of Ensifentrine in COPD ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7688820-en/ Mon, 05 Aug 2019 02:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7688820-en/ <![CDATA[RNS press release - Verona Pharma to Announce Financial Results for Second Quarter Ended June 30, 2019 and Provide Clinical Development Update ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7685764-en/ Tue, 30 Jul 2019 02:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7685764-en/ <![CDATA[RNS press release - Verona Pharma to Attend BTIG Biotechnology Conference 2019 and Present at 2019 Wedbush PacGrow Healthcare Conference ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7682914-en/ Wed, 24 Jul 2019 02:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7682914-en/ <![CDATA[RNS press release - Verona Pharma Strengthens its Clinical Team Ahead of Phase 3 Development of Ensifentrine ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7640153-en/ Tue, 25 Jun 2019 02:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7640153-en/ <![CDATA[RNS press release - Verona Pharma Initiates Phase 2 Clinical Trial with Metered Dose Inhaler Formulation of Ensifentrine for Maintenance Treatment of COPD ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7631112-en/ Tue, 04 Jun 2019 02:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7631112-en/ <![CDATA[RNS press release - Verona Pharma to Present at Jefferies 2019 Global Healthcare Conference ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7629088-en/ Thu, 30 May 2019 02:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7629088-en/ <![CDATA[RNS press release - PDMR Dealing ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20190529110708_14090837/ Wed, 29 May 2019 06:07:08 -0400 https://www.proactiveinvestors.com/companies/rns/1059/LSE20190529110708_14090837/ <![CDATA[RNS press release - Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at American Thoracic Society 2019 International Conference ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7624205-en/ Mon, 20 May 2019 10:15:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7624205-en/ <![CDATA[RNS press release - Result of AGM ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7616774-en/ Tue, 07 May 2019 07:51:41 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7616774-en/ <![CDATA[RNS press release - Verona Pharma Initiates Additional Phase 2b Clinical Trial with Nebulized Ensifentrine to Inform Dose Selection for Phase 3 Trials ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7616458-en/ Tue, 07 May 2019 02:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7616458-en/ <![CDATA[RNS press release - Verona Pharma to Present Clinical Trial Data of Ensifentrine for COPD Maintenance Treatment at American Thoracic Society 2019 International Conference ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7614180-en/ Thu, 02 May 2019 07:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7614180-en/ <![CDATA[RNS press release - Verona Pharma to Announce Financial Results for First Quarter Ended March 31, 2019 and Provide Clinical Development Update ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7613362-en/ Wed, 01 May 2019 02:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7613362-en/ <![CDATA[RNS press release - Verona Pharma to Host Investor & Analyst R&D Forum in London on May 8, 2019 ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7590066-en/ Thu, 25 Apr 2019 07:07:22 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7590066-en/ <![CDATA[RNS press release - Verona Pharma Granted Key EU Patent Related to Late-stage COPD Clinical Candidate Ensifentrine ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7581013-en/ Tue, 09 Apr 2019 02:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7581013-en/ <![CDATA[RNS press release - Grant of Options and RSUs and PDMR Dealings ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7579934-en/ Thu, 04 Apr 2019 02:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7579934-en/ <![CDATA[RNS press release - Verona Pharma to Present at H.C. Wainwright Global Life Sciences Conference ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7564453-en/ Tue, 26 Mar 2019 03:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7564453-en/ <![CDATA[RNS press release - PDMR Dealing ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7563656-en/ Mon, 25 Mar 2019 03:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7563656-en/ <![CDATA[RNS press release - 2018 Annual Report and Accounts and Notice of AGM  ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7563273-en/ Fri, 22 Mar 2019 12:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7563273-en/ <![CDATA[RNS press release - Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7562408-en/ Thu, 21 Mar 2019 03:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7562408-en/ <![CDATA[RNS press release - PDMR Dealing ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7561369-en/ Wed, 20 Mar 2019 03:00:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7561369-en/ <![CDATA[RNS press release - PDMR Dealing ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7557050-en/ Mon, 11 Mar 2019 05:48:25 -0400 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7557050-en/ <![CDATA[RNS press release - PDMR Dealing ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7555353-en/ Thu, 07 Mar 2019 03:14:16 -0500 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7555353-en/ <![CDATA[RNS press release - PDMR Dealing ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7553863-en/ Tue, 05 Mar 2019 04:48:55 -0500 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7553863-en/ <![CDATA[RNS press release - Verona Pharma Reports Positive Interim Data with Ensifentrine Dry Powder Inhaler Formulation in First of Two-Part Phase 2 Clinical Trial in COPD ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7552906-en/ Mon, 04 Mar 2019 02:00:00 -0500 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7552906-en/ <![CDATA[RNS press release - Verona Pharma to Present at Cowen and Company 39th Annual Health Care Conference ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7551119-en/ Thu, 28 Feb 2019 02:00:00 -0500 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7551119-en/ <![CDATA[RNS press release - Verona Pharma Reports Financial Results for Full Year Ended December 31, 2018 and Provides Clinical Development Update ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7549221-en/ Tue, 26 Feb 2019 02:00:00 -0500 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7549221-en/ <![CDATA[RNS press release - Verona Pharma to Announce Financial Results for Full Year ended December 31, 2018 and Provide Clinical Development Update ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7525760-en/ Wed, 20 Feb 2019 02:00:00 -0500 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7525760-en/ <![CDATA[RNS press release - Verona Pharma to Present at Upcoming Investor Conferences ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7497065-en/ Mon, 04 Feb 2019 02:00:00 -0500 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7497065-en/ <![CDATA[RNS press release - Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance Treatment ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7477049-en/ Mon, 14 Jan 2019 02:00:00 -0500 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7477049-en/ <![CDATA[RNS press release - Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554 ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7475230-en/ Wed, 09 Jan 2019 08:00:00 -0500 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7475230-en/ <![CDATA[RNS press release - Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7467123-en/ Mon, 17 Dec 2018 12:20:38 -0500 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7467123-en/ <![CDATA[RNS press release - Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD ]]> https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7466748-en/ Mon, 17 Dec 2018 02:00:00 -0500 https://www.proactiveinvestors.com/companies/rns/1059/NASDAQ_7466748-en/ <![CDATA[News - A sixth sense for biotech helps Arix Bioscience turn risk into profit as portfolio value nearly doubles ]]> https://www.proactiveinvestors.com/companies/news/205476/a-sixth-sense-for-biotech-helps-arix-bioscience-turn-risk-into-profit-as-portfolio-value-nearly-doubles-205476.html Fri, 21 Sep 2018 10:57:00 -0400 https://www.proactiveinvestors.com/companies/news/205476/a-sixth-sense-for-biotech-helps-arix-bioscience-turn-risk-into-profit-as-portfolio-value-nearly-doubles-205476.html <![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20180302164028_13553555/ Fri, 02 Mar 2018 11:40:28 -0500 https://www.proactiveinvestors.com/companies/rns/1059/LSE20180302164028_13553555/ <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20180302163515_13553550/ Fri, 02 Mar 2018 11:35:15 -0500 https://www.proactiveinvestors.com/companies/rns/1059/LSE20180302163515_13553550/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20170530070012_13241445/ Tue, 30 May 2017 02:00:12 -0400 https://www.proactiveinvestors.com/companies/rns/1059/LSE20170530070012_13241445/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20170525172745_13239107/ Thu, 25 May 2017 12:27:45 -0400 https://www.proactiveinvestors.com/companies/rns/1059/LSE20170525172745_13239107/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20170523084429_13235077/ Tue, 23 May 2017 03:44:29 -0400 https://www.proactiveinvestors.com/companies/rns/1059/LSE20170523084429_13235077/ <![CDATA[RNS press release - Partial Exercise of Over-Allotment Option ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20170516074404_13226705/ Tue, 16 May 2017 02:44:04 -0400 https://www.proactiveinvestors.com/companies/rns/1059/LSE20170516074404_13226705/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20170509153646_13219637/ Tue, 09 May 2017 10:36:46 -0400 https://www.proactiveinvestors.com/companies/rns/1059/LSE20170509153646_13219637/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20170508173308_13218178/ Mon, 08 May 2017 12:33:08 -0400 https://www.proactiveinvestors.com/companies/rns/1059/LSE20170508173308_13218178/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20170505153222_13216490/ Fri, 05 May 2017 10:32:22 -0400 https://www.proactiveinvestors.com/companies/rns/1059/LSE20170505153222_13216490/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20170505121518_13216186/ Fri, 05 May 2017 07:15:18 -0400 https://www.proactiveinvestors.com/companies/rns/1059/LSE20170505121518_13216186/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20170505113614_13216084/ Fri, 05 May 2017 06:36:14 -0400 https://www.proactiveinvestors.com/companies/rns/1059/LSE20170505113614_13216084/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20170503180208_13213374/ Wed, 03 May 2017 13:02:08 -0400 https://www.proactiveinvestors.com/companies/rns/1059/LSE20170503180208_13213374/ <![CDATA[RNS press release - Block Listing Application and Review ]]> https://www.proactiveinvestors.com/companies/rns/1059/LSE20170503144900_13213089/ Wed, 03 May 2017 09:49:00 -0400 https://www.proactiveinvestors.com/companies/rns/1059/LSE20170503144900_13213089/ <![CDATA[News - NASDAQ listing for Verona Pharma? ]]> https://www.proactiveinvestors.com/companies/news/127288/nasdaq-listing-for-verona-pharma-127288.html Mon, 20 Jun 2016 09:34:00 -0400 https://www.proactiveinvestors.com/companies/news/127288/nasdaq-listing-for-verona-pharma-127288.html <![CDATA[News - FTSE 100 up 2% as 'remain' camp builds head of steam ]]> https://www.proactiveinvestors.com/companies/news/127273/ftse-100-up-2-as-remain-camp-builds-head-of-steam-127273.html Mon, 20 Jun 2016 06:55:00 -0400 https://www.proactiveinvestors.com/companies/news/127273/ftse-100-up-2-as-remain-camp-builds-head-of-steam-127273.html